
Saralasin
CAS No. 34273-10-4
Saralasin ( —— )
产品货号. M30801 CAS No. 34273-10-4
Competitive non-selective angiotensin II antagonist.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥734 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Saralasin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Competitive non-selective angiotensin II antagonist.
-
产品描述Competitive non-selective angiotensin II antagonist.
-
体外实验Saralasin (1 nM, 48 or 72 h) inhibits cell growth in 3T3 and SV3T3 cells.Saralasin (5 μM, 2h) restores Ito, fast (Fast-Inactivating Transient Outward K+ Current in Mouse Ventricle) and I K, slow (Slow-Inactivating Transient Outward K+ Current in Mouse Ventricl) to control levels in myocytes.Saralasin (0.1-10 nM, 40 min) inhibits binding of FITC-Ang II to rat liver membrane preparation (used as the source of angiotensin receptors) with a Ki value of 0.32 nM for 74% of the binding sites and 2.7 nM for the remaining binding sites.Saralasin (1 μM, perfused rat ovary in vitro) inhibits the ovulation rate versus control and reduces prostaglandin E2 and 6-keto-prostaglandin F1α levels. Cell Proliferation Assay Cell Line:3T3 and SV3T3 cells Concentration:1 nM Incubation Time:48 h, 72 hResult:Inhibited cell growth in 3T3 and SV3T3 cells and caused an increase of cellular renin concentration.
-
体内实验Saralasin (intravenous injection, 5-50μg/kg, a single dose) ameliorates the oxidative stress and tissue injury in cerulein-induced pancreatitis.Saralasin (subcutaneous injection, 10 and 30 mg/kg, a single dose) increases serum renin activity (SRA) in normal, conscious rats, without markedly altering blood pressure or heart rate. Animal Model:Cerulein-induced acute pancreatitis rats model Dosage:5, 10, 20, and 50 μg/kg, a single dose.Administration:Intravenous injection Result:Restored the pancreatic morphological characteristics to the control level.Reduced pancreatic injury and suppressed the glutathione depletion induced by cerulean.Animal Model:Male Sprague-Dawley rats Dosage:10 and 30 mg/kg, a single dose.Administration:Subcutaneous injection Result:Stimulated renin release without altering blood pressure or heart rate at the time of measuring serum renin levels 20 minutes after injection.
-
同义词——
-
通路GPCR/G Protein
-
靶点Angiotensin Receptor
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number34273-10-4
-
分子量912
-
分子式C42H65N13O10
-
纯度>98% (HPLC)
-
溶解度water:1 mg/mL
-
SMILES[H]N(C)CC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Steinhausen et al (1986) Angiotensin II control of the renal microcirculation: effect of blockade by saralasin. Kidney Int. 30 56 PMID:
产品手册




关联产品
-
Losartan potassium
一种选择性、竞争性 1 型血管紧张素 II 受体 (AT1) 拮抗剂 (IC50=20 nM),用于治疗高血压(高血压)。
-
Norleual
Angiotensin IV analog. Highly potent HGF/c-MET inhibitor (IC50 = 3 pM). Inhibits HGF-induced MDCK cell proliferation and invasion in vitro. Also AT4 receptor antagonist; disrupts LTP stabilization. Antiangiogenic.
-
EMA300
EMA300 (PD1 21981) 是一种有效的选择性血管紧张素 II 2 型受体 (AT2R) 小分子拮抗剂。